NC Dolan, K Freund, J Walsh, TM Hooton, D … - Annals of internal …, 2000 - Am Coll Physicians In selecting the articles for this Update, we systemati- cally reviewed the literature and consulted
our col- leagues to identify important papers on women's health published in 2000. We critically
examined the content and methods of the studies identified and selected 10 articles that ... Related articles - All 4 versions
KA Schulman, EA Stadtmauer, SD Reed, HA … - Bone Marrow …, 2003 - nature.com We performed an economic analysis of data from 180 women in a clinical trial of
conventional-dose chemotherapy vs high-dose chemotherapy plus stem-cell transplantation
for metastatic breast cancer responding to first-line chemotherapy. Data on resource use, ... Cited by 21 - Related articles - BL Direct - All 5 versions
SF Williams, SE Myers, S Huffman, R Mick, JD … - Breast cancer research …, 1993 - Springer We treated 39 women with newly diagnosed stage IV breast cancer with a new regimen of mitoxantrone
18 mg/m 2 on days 1, 29, 57, vincristine 1.4 mg/m 2 (maximum 2.0 mg) on days 1, 8, 15, 22,
29, 36, 43, 50, and 5-fluorouraci1375 mg/m 2 on days 15-20, 4347, 71-75 with leucovorin ... Cited by 1 - Related articles - BL Direct - All 4 versions
SJ Vukelja, WJ Baker, MYJ Atkins, N Lee, JJ … - The Breast …, 1998 - interscience.wiley.com Abstract:Fifty-four patients with metastatic breast cancer were treated with high-dose paclitaxel
(200 mg/m 2 ), cyclophosphamide (5,625 mg/m 2 ) and cisplatin (165 mg/m 2 ) with autologous
stem cell support. Median age of the group was 43 years (range 24–58); half of the ... Cited by 1 - Related articles
MJ Kennedy - Journal of Clinical Oncology, 1995 - jco.ascopubs.org C ontroversy over the value of high-dose chemother- apy in the treatment of breast cancer has
been fu- eled by the absence of data from randomized clinical trials. In patients with metastatic
breast cancer, small phase II studies, often treating only women with disease sensitive to ... Cited by 33 - Related articles - View as HTML - BL Direct - All 5 versions
WR Bezwoda, F PhD - European Journal of Cancer Care, 1997 - interscience.wiley.com The development of more effective treatment strategies currently provides the only realistic hope
of reducing breast cancer mortality. Among such treatments, the use of high-dose chemotherapy
(HDC) has been proposed as a potentially curative strategy. Consideration of the factors ... Cited by 2 - Related articles - BL Direct - All 2 versions
DT Vogl, EA Stadtmauer - Bone Marrow Transplantation, 2006 - nature.com Jump to main content; Jump to navigation; nature.com homepage; Publications AZ
index; Browse by subject. My account; Submit manuscript; Register; Subscribe. Login.
Bone Marrow Transplantation homepage Search This journal. ... Cited by 4 - Related articles - BL Direct - All 3 versions
EA Stadtmauer, A O'Neill, LJ Goldstein, PA … - The New England …, 2000 - nejm.highwire.org Results The median follow-up was 37 months. Of 553 patients who enrolled in the study, 58 had
a complete response to induction chemotherapy and 252 had a partial response. Of these, 110
patients were assigned to receive high-dose chemotherapy plus hematopoietic stem cells ... Cited by 292 - Related articles - BL Direct - All 6 versions
FR DUNPHY, G SPITZER - JNCI Journal of the National Cancer …, 1992 - jnci.oxfordjournals.org (/) COUNCIL ON ETHICAL AND JUDICIAL AF- FAIRS, AMERICAN MEDICAL
ASSOCIATION: Use of genetic testing by employers. JAMA 266:1827-1830, 1991 (2) GOODFELLOW
PN, SEFTON L: Human genetics. Language of the genome. Nature 353:117-118,1991 (3) ... Cited by 30 - Related articles - View as HTML - All 4 versions
